Romans 12:19
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$RLFTF DD by OU2 on Yh-0: Remember - As part of a new agreement with AdVita Lifescience, Relief Therapeutics will acquire the intellectual rights for the specifications and potential applications of an inhaled formulation of RLF-100 (aviptadil).
By acquiring the rights to AdVita’s therapy formulation, Relief also will accelerate and secure RLF-100’s future development as an inhaled therapy for lung diseases, such as pulmonary sarcoidosis, that are associated with COVID-19. Other lung diseases associated with COVID-19, which also could potentially be treated by RLF-100, include checkpoint inhibitor-induced pneumonitis, and acute respiratory distress syndrome (ARDS).
Of note, the other current formulation of RLF-100 is as an intravenous (into-the-vein) infusion.
Relief is getting the intellectual rights to RLF-100 as part of a binding term agreement in which it will acquire all shares of AdVita, along with several company assets.
“AdVita’s intellectual property around inhaled formulations of Aviptadil and its team’s expertise with Aviptadil will be invaluable as we move forward with the development of the inhaled formulation of RLF-100 for the treatment of COVID-19-related ARDS, as well as other potential lung disease indications, such as pulmonary Sarcoidosis,” Jack Weinstein, chief financial officer and treasurer of Relief, said in a press release.
“We look forward to initiating the development of inhaled RLF-100 in Europe within the coming months for COVID-19 patients using inhaled Aviptadil.
..noticed that... mhh ?
47 stocks were profiled yesterday.. you can count here..(below) in the last 2 days lots of good things came out of the spat.. including more positive proof we got the goods and all of the investors in other symbols related to RLFTF got a good look at the % cuts and where the patents live ;) so we're in better shape IMO
https://investorshub.advfn.com/ClayTradercom-27618/
They still hold the patent. GEM will scold 'em both into shape. ..maybe this is just a share grab before the EUA breakout..
aw man.. I'm starting to think Merida is the Richard Gere in Pretty woman and we just got fired, broken up, sold off and they're trying to keep the Mexican scraps for their own companies.. I was wondering w/a few on the board .. did they have the ability to change that status of their shares from common to another type which won't be effected ? Carlos seems to be doing alright in a private business and his brother was paid well.. God bless 'em.
$RLFTF (related) US Coronavirus: The US made little progress this week in preventing more deaths, an influential forecasting team says
https://www.msn.com/en-us/news/us/us-coronavirus-the-us-made-little-progress-this-week-in-preventing-more-deaths-an-influential-forecasting-team-says/ar-BB1fKl3l?ocid=BingNewsSearch
..it says they believe RLF-100 works and is worth investing millions of dollars.. RLFTF gets their cut.. IMO
..from tcm55 : The 'Jewel' is still RLF-100. Dispite the retorect from NRX the partnership is Relief 80-20% throughout the WORLD and 50-50% US/I/Ca for commercialization of RLF-100.
New Swiss and Turkey Inhaler Trials for Aviptadil by RLF are super significant, IMO.
... from October to December it was apart of the talks along with people avoiding double lung transplants, people coming off of Vents.. etc.. that's why it's maddening for some of us.. Vac's for healthy people were being pushed through and known therapeutics with problem histories were favored.. while we were given positive results along w/another no go.. something is really wrong here. IMO maybe as the bodies pile up the powers that be will be forced to finally deal from the top of the deck.
..correct on the wording ... even today Relief stated they will be filing.. below is a post from today on ya-h00 that explains my earlier view.. and adds to the confusion.. ;)
Post by Relief 2 hours ago
The EUA application has been ongoing since it was originally filed back in September. No new application needed if you listen to Dr. J. In December, the request was denied as submitted based on the small patient set.
Understandable. Dr. J continued to work with the FDelay on what was an appropriate sample size. The RCT trial was designed with the approval of the FDA. The endpoints were approved by the FDA. We provided the agreed upon sample size and the results met the endpoints across ALL patients and sites at 28 and 60 days.
Incredible. No better therapeutic to help critical C19 patients. The FDelay is well aware of what has been accomplished by Zyesami from EAP and RCT patient results.
Soon the world will know. Please relax, the EUA is already under consideration by the FDelay for this amazing therapeutic. Tick tock, buy more of this stock while you wait.
12 cents G&33hm
:) Thanks
Have a good day.
I was under the impression that we're still going off of the original EUA application and this is really isn't an issue.
nah, there were 2 others posting about replies.. the way things are going maybe the FDA will finally deal from the top of the deck ??
She's on ya-h00
..that's a copy of a msg. by Elisabeth.. was an impersonal IR email from a ya-h00 post..
$RLFTF DD by Elizabeth - A more scholarly medical view of Aviptadil from India.
https://www.babymhospital.org/BMH_MJ/index.php/BMHMJ/article/download/300/641
----
From Janet Woodcock yesterday after I emailed her how much the world needs this therapeutic and how Covid has affected our family. “Thanks for writing. As you know the FDA can’t talk about our actions on investigational drugs. I can assure you we are well aware of Aviptadil.”
- Elizabeth
..yes I believe they used this filter in the Ebola outbreak a few years ago.. might be the same health tech ...
Aethlon-Medical-Inc A E M D
Yeshua
Absolutely .. so brutal the neglect ... FDA = MS13 in suits
I've paid from .20 to .79 and lack of belief (hype) is not what is holding this up.. IMO Gr$$D only in America !!
..it will come.. we built it.. :)
#NeuroRx $RLFTF $BRPA #TheMath
GENEVA, Switzerland and RADNOR, Pa. , Sept. 21, 2020 /PRNewswire/ --
RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) Relief Therapeutics and NeuroRx, Inc. today announced the completion of their partnership agreement for the commercialization of RLF-100™(Aviptadil)
(Zyesami ) worldwide.
The two organizations have agreed to share all profits from sales of RLF-100 for all indications related to COVID-19 and potentially other respiratory indications on a global basis.
They have agreed that NeuroRx will lead commercialization in the United States , Canada , and Israel , while Relief will lead commercialization in Europe and the rest of the world.
Profits from sales will be allocated to Relief and NeuroRx on a 50/50 basis in the U.S., Canada and Israel , 85/15 (in favor of Relief) in Europe , and 80/20 (in favor of Relief) in all other territories.
https://www.prnewswire.com/news-releases/relief-and-neurorx-announce-partnership-for-global-commercialization-of-rlf-100-and-selection-of-commercial-partners-301134379.html
$RLFTF Dr Javitt on Fox Business
Video here: https://streamable.com/dwb2fy
$RLFTF Dr Javitt on Fox Business
Video here: https://streamable.com/dwb2fy
$MSTO ..just sitting on the Tarmac..
Why Your Stock is Always Red
Feb 18 Written By David Stone
https://www.griproom.com/fun/why-your-stock-is-always-red
..for sure.. I'm out.. but just read this on another board.. or is this a Company we sold CBD to.. ? .. I left the .79's on the table in oct19 but took the .33's earlier from my .05's so I walk away w/less regret.. ugh!!
Is Green Lotus coming out of bankruptcy? New store locations in the California Bay Area. Looks like they are still in the game. https://www.facebook.com/greenlotushemp
The Merida shares are commons.. no ?
$RLFTF (related) NeuroRx NeuroRxPharma · 8h Listen to our 3/29 investor call on ZYESAMI™ demonstrating significant benefit in critical #COVID19 survival and meeting the primary endpoint of phase 2b/3 clinical trial:
https://bit.ly/3dt7MOP
aviptadil ZYESAMI
...caught that.. I was focused on the "We don't just invest in cos, we build them." part.. ~ (et al.) ~
$GRLB mmmh ??? Chop Chop !!! ..assuming we're the et al.
Merida Capital Holdings
@MeridaCap
Cannabis-focused PE Fund w/ 57 portcos. We don't just invest in cos, we build them. $MCMJ $GRWG $SHGFF $CRLBF $VREOF $JUSHF et al.
$GRLB Merida Capital Holdings
@MeridaCap
·
4m
New Mexico, NY, AZ...hmmm is any MSO currently big in those 3 places? Anyone, Bueller?
New Mexico, NY, AZ...hmmm is any MSO currently big in those 3 places? Anyone, Bueller?
— Merida Capital Holdings (@MeridaCap) April 1, 2021
I don't believe anyone asked for financial advice here..
yes FDA EUA Emer. use auth.
I believe this is for EUA not NDA.. I'm guessing that would require what you mention ... but these are pandemic moves.. IMO
..kinda crazy we can't get a hint.. but the journal can and inside buy.. Ha!
$RLFTF (related) US Stock Exchanges closed Friday
SIX Exchange closed Friday & Monday
$RLFTF Interesting Ya-h0 thread: Julie
Per the FDA guidelines for EUA on their website: FDA is prepared to issue EUAs expeditiously (e.g., within hours or days) when circumstances warrant and adequate information has been made available
———————
c. Disposition of Requests
FDA is prepared to issue EUAs expeditiously (e.g., within hours or days) when circumstances warrant and adequate information has been made available for prior review through pre-EUA interactions. Generally, the timelines for FDA review and action on a request to issue an EUA will be determined on a case-by-case basis and will depend on factors such as:
The product profile;
The existence, if any, of pending applications for the product;
The nature of the emergency, potential emergency, or threat of emergency;
The organization and completeness of the request submission; and
The workload of the reviewing Center’s personnel.
some replies..
Max
I think we will have the EUA, but the FDA could have already give it in September, for now it has only lost 6 months of human lives
Kevin
Promising
Goose
just a question- don't you think this would have already happened if it could save lives? a long time ago?
----
Ginger
Sugar,
If their urgency didn't change with 3,000+ deaths per day, I doubt 1,000 will place Zyesami on top of the paper pile. They approved Lilly's drug and have now revoked it due to loss of efficacy against variants. They could have done the same with Zyesami with 0 risk knowing it is 100% safe and is indifferent to variants - it still works.
Just 1 life saved is everything to the family who lost that loved one. Multiply that by 1000 families each and every day. They fell asleep at the wheel while the titanic continued toward the iceberg and barreled into it. We've taken on water, but only the steerage see it for now. These new variants will continue to reduce efficacy of existing vaccines, especially the targeted mRNA ones. Mother Nature can patch the holes, you just have to let her work her magic.
Follow the money
----
My reply after 9 months is rrrrrrrrrrrr W-T-F !!!! I've been beyond reason for awhile now.. copy and paste man that's all... G. -ave mercy!!!!
$RLFTF View of Role of Aviptadil in COVID-19 | BMH Medical Journal - ISSN 2348–392X
https://www.babymhospital.org/BMH_MJ/index.ph...ew/300/631
" Conclusion Synthetic VIP, Aviptadil is found to reduce viral replication in lung tissues, release of inflammatory cytokines and alveolar epithelial cell apoptosis in patients with corona virus infection. On-going clinical trials will be expected to through more light into the role of Aviptadil in COVID-19. "